Topic Archives: Partner Communications (PTNR)

Comments

  • Travis Johnson, Stock Gumshoe

    We keep seeing this ad and getting more questions about it -- the ad hasn't changed in any big way that I've noticed, th...

  • Avatar

    I've often wondered how companies that develop something that eliminates disease, such as this, will make money. The OUT...

  • Avatar

    $12 trillion? That's over half of the US economy. Even over 10 years, it's never going to happen. I guess for $79/yea...

  • Avatar

    Well I just hope this is a boomer like the "God Key" stocks (EDIT, CRSP) which are about 50% lower from their peaks in 2...

  • Avatar

    Although the last three months is a short time period, it's the only one I could research easily. Over that period, the...

  • Avatar

    I think its cell data. https://www.investors.com/news/technology/crispr-gene-editing-biotech-companies/ https://mo...

  • Avatar

    There've been a lot of uncertainties around the CRISPR companies, but I think right now the elephant in the room is the ...

  • Avatar

    Found the article I remember that talks about the patent license. https://www.forbes.com/sites/matthewherper/2015/08/10/...

  • Avatar

    Amazing how they can predict uranium demand (prices) over the next 15 years or more. After you've spent about $75,000-$...

  • Avatar

    Thanks for putting everything into perspective. I read about "exciting new developments" every day, and it is impossibl...

  • Avatar

    I bought CRSP and I am up over 60%. Might think about the other two as well. This technology will take some time to deve...

  • Avatar

    I gave up on EDIT, NTLA, and CRSP and went with Illumina, Inc. (ILMN) which is similar but much less volatile. And ILMN ...

  • Avatar

    If you read all the way down to the end of Altucher's epic screed you see that he says you should buy all three: EDIT, N...

  • Travis Johnson, Stock Gumshoe

    I have a really hard time with R&D companies or very early-stage clinical biotechs -- partly because it's an end market ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info